Rangachari, D., VanderLaan, P. A., Shea, M., Le, X., Huberman, M. S., Kobayashi, S. S., & Costa, D. B. (2017). Correlation between classic driver oncogene mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% expression in lung adenocarcinoma. J Thorac Oncol.

Rangachari, Deepa, Paul A. VanderLaan, Meghan Shea, Xiuning Le, Mark S. Huberman, Susumu S. Kobayashi, و Daniel B. Costa. "Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma." J Thorac Oncol 2017.

Rangachari, Deepa, et al. "Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma." J Thorac Oncol 2017.